Search Results - david+kang

1 Results Sort By:
Inhibition of Beta-Arrestin 1 and Beta-Arrestin2 Oligomerlzation in Taupathy
Competitive Advantages Small molecule inhibitors that target beta-arrestin oligomerization and accumulation of pathogenic tau Novel treatment for tauopathies Could be a therapeutic for numerous neurodegenerative disorders Summary Tau pathology (tauopathy) is a prevailing hallmark of multiple neurodegenerative disease, including Alzheimer’s...
Published: 5/23/2024   |   Inventor(s): Jung A Woo, Stephen Liggett, David Kang
Keywords(s): Neurodegenerative Diseases, Therapeutics
Category(s): Technology Classifications > Medical > Neuroscience, Technology Classifications > Medical